# Thomas Eldered

> Thomas Eldered is a Series A investor at Flerie Invest backing Pharmaceutical and Medical. See 6 investments, check sizes, portfolio. Updated Aug 2026.

- Type: Angel Investor
- Fund: [Flerie Invest](https://shizune.co/investors/profile/flerie-invest)
- Location: Jordbro, Sweden
- Total investments: 6
- Last investment: Oct 2025
- Lead investor: 50%
- Last updated: Aug 2026
- LinkedIn: https://www.linkedin.com/in/thomas-eldered-14952919

Thomas Eldered is a Series A investor at Flerie Invest in Jordbro focused on Pharmaceutical and Medical. Thomas Eldered - Executive Chairman @ Flerie Invest

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Pharmaceutical | 2 | 33% |
| Medical | 1 | 17% |
| Biotechnology | 1 | 17% |

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Series A | 1 | 17% |
| Series B | 1 | 17% |
| Corporate Round | 1 | 17% |
| Venture - Series Unknown | 1 | 17% |

### Country

| Country | Investments | Share |
| --- | --- | --- |
| Israel | 1 | 17% |
| Germany | 1 | 17% |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| KAHR medical | KAHR Medical ("KAHR") is pioneering the development of "third generation biological drugs," a unique class of proprietary fusion-protein molecules with clear and far-reaching advantages. KAHR's technology represents a paradigm shift in protein-based pharmaceuticals that will significantly expand available treatment optionsfor cancer and autoimmune disorders. | $22M | Series B | Oct 15, 2025 |  |
| Coriolis Pharma | Coriolis Pharma is a globally operating independent service provider for research and development of biopharmaceutical drugs. |  | Corporate Round | Oct 16, 2023 |  |
| KAHR medical | KAHR Medical ("KAHR") is pioneering the development of "third generation biological drugs," a unique class of proprietary fusion-protein molecules with clear and far-reaching advantages. KAHR's technology represents a paradigm shift in protein-based pharmaceuticals that will significantly expand available treatment optionsfor cancer and autoimmune disorders. | $46.5M | Venture - Series Unknown | Jun 16, 2021 |  |
| KAHR medical | KAHR Medical ("KAHR") is pioneering the development of "third generation biological drugs," a unique class of proprietary fusion-protein molecules with clear and far-reaching advantages. KAHR's technology represents a paradigm shift in protein-based pharmaceuticals that will significantly expand available treatment optionsfor cancer and autoimmune disorders. | $18M | Venture - Series Unknown | Feb 25, 2020 |  |
| KAHR medical | KAHR Medical ("KAHR") is pioneering the development of "third generation biological drugs," a unique class of proprietary fusion-protein molecules with clear and far-reaching advantages. KAHR's technology represents a paradigm shift in protein-based pharmaceuticals that will significantly expand available treatment optionsfor cancer and autoimmune disorders. | $12M | Series B | Dec 01, 2015 |  |
| KAHR medical | KAHR Medical ("KAHR") is pioneering the development of "third generation biological drugs," a unique class of proprietary fusion-protein molecules with clear and far-reaching advantages. KAHR's technology represents a paradigm shift in protein-based pharmaceuticals that will significantly expand available treatment optionsfor cancer and autoimmune disorders. | $2.5M | Series A | Sep 01, 2013 |  |

6 of 6 investments shown.

## Co-investors
- [Mirae Asset Venture Investment](https://shizune.co/investors/profile/mirae-asset-venture-investment) — VC Fund, 3 deals together
- [Oriella Ltd.](https://shizune.co/investors/profile/oriella-ltd) — VC Fund, 3 deals together
- [aMoon Fund](https://shizune.co/investors/profile/amoon) — VC Fund, 2 deals together
- [Cancer Focus Fund](https://shizune.co/investors/profile/cancer-focus-fund) — VC Fund, 2 deals together
- [HBL Hadasit Bio Holdings](https://shizune.co/investors/profile/hbl-hadasit-bio-holdings) — VC Fund, 2 deals together
- [Pavilion Capital](https://shizune.co/investors/profile/pavilion-capital) — VC Fund, 2 deals together

## About Flerie Invest

VC Fund

Flerie Invest is a Europian investment firm that makes investments in the health care sector companies.

2 contacts available at Flerie Invest.

| Name | Title | Profile |
| --- | --- | --- |
| Thomas Eldered | Executive Chairman | https://shizune.co/investors/profile/thomas-eldered |
| Ted Fjällman | Partner | https://shizune.co/investors/profile/ted-fj%C3%A4llman |

## Similar investors

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [General Catalyst](https://shizune.co/investors/profile/general-catalyst-partners) — VC Fund

## FAQ

### What does Thomas Eldered invest in?

Thomas Eldered invests primarily in Pharmaceutical, Medical and Biotechnology startups, most often at Series A and Series B stage. Most of the 6 investments tracked by Shizune back companies in Israel. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### When did Thomas Eldered last invest?

The most recent investment recorded for Thomas Eldered closed in Oct 2025. Shizune tracks 6 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co